Creatine Supplementation in Concussion Recovery
Launched by SAN DIEGO STATE UNIVERSITY · Jan 16, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how creatine, a common dietary supplement, might help people recover from concussions faster. The researchers want to see if individuals taking creatine feel better sooner and show improved scores on various tests that measure symptoms, mental function, balance, and coordination compared to those who are not taking creatine. They believe that those who take creatine will have fewer symptoms and perform better on these assessments once they are no longer feeling the effects of the concussion.
To participate in this study, you must be between 18 and 35 years old and have been diagnosed with a concussion within the last 72 hours. However, if you have a learning disability, kidney disease, a history of mental health issues or migraines, or have taken creatine in the past six weeks, you may not be eligible. Participants in the trial will take either creatine or a placebo (a non-active substance) and will undergo tests to track their recovery over time. This study is currently looking for volunteers, so if you or someone you know fits the criteria and is interested, it might be a great opportunity to contribute to important research on concussion recovery!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-35 years old with a diagnosed concussion within 72 hours post-injury
- Exclusion Criteria:
- • Learning disability, renal disease, mental behavior or migraine history, and current creatine use or have not taken creatine in the past 6 weeks
About San Diego State University
San Diego State University (SDSU) is a leading academic institution recognized for its commitment to research and innovation in various fields, including health sciences. With a robust infrastructure for clinical trials, SDSU engages in cutting-edge research aimed at advancing medical knowledge and improving patient care. The university fosters collaboration among interdisciplinary teams of researchers, clinicians, and students, enabling the development of novel therapeutic interventions and evidence-based practices. SDSU's dedication to ethical standards and rigorous scientific methodologies ensures that its clinical trials contribute valuable insights to the medical community and enhance public health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Patients applied
Trial Officials
Michelle Weber Rawlins
Principal Investigator
San Diego State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported